Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia

NCT03844997 is registered in ClinicalTrials.gov with Sudipto Mukherjee, MD, PhD, MPH as lead sponsor.

NCT NCT03844997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03844997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia
Lead sponsor
Sudipto Mukherjee, MD, PhD, MPH
Phase
Phase 1/2
Overall status
Completed
Start date
June 6, 2019
Completion date
January 24, 2024
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, aml